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us—and other readers—whether gender independently influenced
clinical outcome.
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REPLY
We would like to thank Dr. Poulsen and colleagues for their
interest in our study (1). The prevalence of female gender with or
without creatine kinase-myocardial band (CK-MB) elevation after
percutaneous coronary intervention (PCI) was not different be-
tween the two groups (31.1% vs. 21.7%; p  0.22). Gender was
entered in the multivariate analysis, and it turned out not to be an
independent predictor of CK-MB elevation.
Women undergoing balloon angioplasty had a higher incidence
of early adverse cardiac events in both early (2) and contemporary
series (3). In the current era of predominant stent implantation for
PCI, mixed results have been demonstrated (4–6). However, our
data concur with recent studies specifically addressing post-PCI
myonecrosis, in which female gender is not demonstrated to be an
independent correlate of post-PCI myonecrosis (7–9).
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